Janney Montgomery Scott LLC Invests $559,000 in Astera Labs, Inc. $ALAB

Key Points

• Janney Montgomery Scott LLC has made a significant investment of $559,000 in Astera Labs, Inc., acquiring 6,183 shares during the second quarter.
• Astera Labs reported a 149.5% year-over-year increase in revenue for the last quarter, with earnings per share beating estimates at $0.44.
• Institutional ownership of Astera Labs stands at 60.47%, with several firms, including Alliancebernstein L.P. and Bank of Nova Scotia, significantly increasing their stakes.

Janney Montgomery Scott LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,183 shares of the company's stock, valued at approximately $559,000.

Other institutional investors have also recently bought and sold shares of the company. Alliancebernstein L.P. raised its holdings in shares of Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock valued at $501,289,000 after purchasing an additional 4,478,741 shares during the last quarter. Atreides Management LP raised its holdings in shares of Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock valued at $277,601,000 after purchasing an additional 2,815,614 shares during the last quarter. Bank of Nova Scotia grew its position in Astera Labs by 3,742.2% in the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock valued at $57,546,000 after purchasing an additional 939,300 shares in the last quarter. Jump Financial LLC bought a new position in Astera Labs in the first quarter valued at $32,998,000. Finally, Pacer Advisors Inc. bought a new position in Astera Labs in the first quarter valued at $29,935,000. Institutional investors own 60.47% of the company's stock.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $163.55 on Friday. The business has a fifty day simple moving average of $200.07 and a two-hundred day simple moving average of $127.18. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The company has a market capitalization of $27.19 billion, a price-to-earnings ratio of 292.05, a P/E/G ratio of 4.02 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same period in the prior year, the firm earned $0.13 earnings per share. The company's revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ALAB has been the subject of a number of recent research reports. TD Cowen initiated coverage on shares of Astera Labs in a research note on Wednesday, October 1st. They set a "hold" rating and a $200.00 price objective for the company. Needham & Company LLC upped their target price on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Bank of America began coverage on Astera Labs in a report on Friday, October 3rd. They set a "neutral" rating and a $230.00 target price on the stock. Citigroup boosted their price target on Astera Labs from $160.00 to $275.00 and gave the stock a "buy" rating in a research report on Wednesday, September 17th. Finally, CICC Research initiated coverage on Astera Labs in a research report on Friday, August 29th. They set an "outperform" rating and a $190.00 price target on the stock. Fifteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat, Astera Labs has an average rating of "Moderate Buy" and a consensus price target of $159.83.

Insiders Place Their Bets

In related news, Director Stefan A. Dyckerhoff sold 25,000 shares of Astera Labs stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $173.42, for a total transaction of $4,335,500.00. Following the completion of the sale, the director directly owned 99,154 shares of the company's stock, valued at approximately $17,195,286.68. This trade represents a 20.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the sale, the chief operating officer directly owned 5,525,545 shares of the company's stock, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,182,514 shares of company stock worth $202,298,671 in the last 90 days. Corporate insiders own 12.50% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.